AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
16.26 USD
-0.31 (-1.87%)
16.26 USD
0 (0%)
Overall AMN gets a fundamental rating of 4 out of 10. We evaluated AMN against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of AMN get a neutral evaluation. Nothing too spectacular is happening here. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
In the past year AMN had a positive cash flow from operations.
Of the past 5 years AMN 4 years were profitable.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AMN (-12.88%) is worse than 76.24% of its industry peers.
With a Return On Equity value of -42.76%, AMN is not doing good in the industry: 72.28% of the companies in the same industry are doing better.
AMN has a Return On Invested Capital of 2.08%. This is comparable to the rest of the industry: AMN outperforms 46.53% of its industry peers.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.22%.
The last Return On Invested Capital (2.08%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (1.65%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AMN has declined.
The Gross Margin of AMN (29.37%) is comparable to the rest of the industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.41 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score of 2.41. This is comparable to the rest of the industry: AMN outperforms 53.47% of its industry peers.
The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AMN (3.80) is better than 73.27% of its industry peers.
AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
AMN has a worse Debt to Equity ratio (1.31) than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.27
WACC7.78%
2.3 Liquidity
AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN has a worse Current ratio (1.05) than 67.33% of its industry peers.
AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.05, AMN is not doing good in the industry: 61.39% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.29%.
AMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.80% yearly.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.42%.
Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
The Revenue is expected to grow by 4.40% on average over the next years.
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.38%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.60, the valuation of AMN can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 94.06% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.46, AMN is valued rather cheaply.
With a Price/Forward Earnings ratio of 15.58, AMN is valued correctly.
75.25% of the companies in the same industry are more expensive than AMN, based on the Price/Forward Earnings ratio.
AMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 15.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 83.17% of the companies are valued more expensively.
AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 99.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.8 | ||
| EV/EBITDA | 6.95 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -22.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)10.69
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.26
-0.31 (-1.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.78%
Inst Owner Change0.2%
Ins Owners0.43%
Ins Owner Change0.71%
Market Cap624.55M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.13 (29.95%)
Short Float %6.73%
Short Ratio2.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)4.64%
PT rev (3m)3.17%
EPS NQ rev (1m)46.18%
EPS NQ rev (3m)30.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.24%
Revenue NQ rev (1m)16.48%
Revenue NQ rev (3m)14.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 15.58 | ||
| P/S | 0.23 | ||
| P/FCF | 2.8 | ||
| P/OCF | 2.34 | ||
| P/B | 0.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.95 |
EPS(TTM)1.89
EY11.62%
EPS(NY)1.04
Fwd EY6.42%
FCF(TTM)5.8
FCFY35.67%
OCF(TTM)6.94
OCFY42.7%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.69
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.41 |
F-Score4
WACC7.78%
ROIC/WACC0.27
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.38%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year92.53%
EBIT Next 3Y25.77%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.